Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.37B | 1.46B | 1.76B | 547.00M | 1.19B |
| Total Depreciation and Amortization | 363.00M | 366.00M | 354.00M | -397.00M | 387.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | 803.00M | -- |
| Total Other Non-Cash Items | -545.00M | 44.00M | -446.00M | -345.00M | 309.00M |
| Change in Net Operating Assets | 84.00M | 40.00M | 2.66B | -524.00M | -750.00M |
| Cash from Operations | 1.27B | 1.91B | 4.33B | 84.00M | 1.14B |
| Capital Expenditure | -267.00M | -287.00M | -235.00M | -293.00M | -360.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.00M | 0.00 | 5.00M | 33.00M | 1.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.72B | 446.00M | -1.41B | 724.00M | -865.00M |
| Cash from Investing | -1.99B | 159.00M | -1.64B | 464.00M | -1.22B |
| Total Debt Issued | 331.00M | -70.00M | 1.04B | 1.56B | 3.54B |
| Total Debt Repaid | 1.18B | -854.00M | -2.05B | -542.00M | -2.07B |
| Issuance of Common Stock | 25.00M | 26.00M | 37.00M | 58.00M | 0.00 |
| Repurchase of Common Stock | -331.00M | -235.00M | -1.16B | -472.00M | -867.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -373.00M | -373.00M | -376.00M | -377.00M | -381.00M |
| Other Financing Activities | 5.00M | 12.00M | -3.00M | 12.00M | 21.00M |
| Cash from Financing | 838.00M | -1.49B | -2.52B | 236.00M | 243.00M |
| Foreign Exchange rate Adjustments | -2.00M | -3.00M | -9.00M | -6.00M | -1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.00M | 575.00M | 166.00M | 778.00M | 153.00M |